Nachrichten zur Merck & Co. Inc. Aktie

Top Research Reports for Merck, ServiceNow & Blackstone

Todays Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), ServiceNow, Inc. (NOW)…

SAP, Merck und Mercedes dabei: Das sind 2024 bisher die Top-Aktien im DAX. Geht da jetzt noch mehr?

Der DAX ist gerade erst wieder auf ein neues Rekordhoch geklettert, da lohnt sich ein Blick auf die Index-Aktien, die…

Global Study on Animal Health Market Size & Share Projected to Reach USD 149.02 Billion By 2032, with 10.5% CAGR growth: Polaris Market Research

The global animal health market size and share is currently valued at USD 60.72 billion in 2023. It is anticipated…

Merck: Qube Research & Technologies setzt Leerverkauf-Aktivitäten fort - Aktiennews

Darmstadt (www.aktiencheck.de) - Shortseller Qube Research & Technologies Limited hat Short-Position in Aktien der Merck KGaA kräftig gesteigert: Die Leerverkäufer des…

Merck wins Canada approval for gastric cancer combination therapy

…

[Latest] Global Conductive Polymers Market Size/Share Worth USD 10.54 Billion by 2032 at a 7.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

Pharma Stock Roundup: AZN & LLYs Q4 Earnings, NVO, NVS & MRKs M&A Deals

Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.…

Heres Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month

Investors are still excited about obesity treatments and weight-management drugs.…

Pharma Stocks: 5 Biggest Companies in 2024

The pharmaceutical industry is a major player in the life science sector, responsible for developing and manufacturing the majority of…

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

The push to cut drug prices is one of those rare hot-button issues that unites the two major political parties.…

Merck: Qube Research & Technologies startet Short-Aktivitäten - Aktiennews

Darmstadt (www.aktiencheck.de) - Shortseller Qube Research & Technologies Limited baut Short-Position in Aktien der Merck KGaA auf: Die Leerverkäufer des Hedgefonds…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA vor Zahlen zum vierten Quartal auf…

Merck (MRK) Unit to Buy Elancos Aqua Business for $1.3B

Mercks (MRK) Animal Health unit is set to strengthen its position with the acquisition of Elanco Animal Healths aqua business…

Elanco Animal Health sells aqua business to Merck for $1.3 billion

Elanco Animal Health Inc has announced the sale of its aqua business to Merck Animal Health for US$1.3 billion in…

Elanco’s stock heads for 18-month high as company sells aqua business to Merck for $1.3 billion in cash

The deal “allows us to prioritize our investments in larger markets with greater earnings potential over the medium and long…

Pharma Stock Roundup: PFE, MRK, NVO & SNYs Q4 Earnings, FDA Updates

Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.…

Merck (MRK) Q4 2023 Earnings Call Transcript

MRK earnings call for the period ending December 31, 2023.…

Merck & Co., Inc. (MRK) Q4 2023 Earnings Call Transcript

…

Merck, Walgreens and Amgen lead way as Dow’s intraday gain hits 200 points

…

Get Jim Cramer’s rapid-fire takeaways on 5 stocks in the news Thursday

Morning meeting rapid fire: Merck, Align, Royal Caribbean, Etsy, Peloton…

World Electrophoresis Equipment and Supply Industry Report 2024-2030 Featuring Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, and Merck Millipore

Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Electrophoresis Equipment and Supply Market Report: Trends, Forecast and Competitive…

Merck posts better-than-expected results on Keytruda sales jump By Reuters

Stocks making the biggest moves premarket: Qualcomm, Merck, General Motors and more

These are the stocks posting the largest moves in premarket trading.…

WDH: Hohe Forschungskosten sorgen für Gewinneinbruch beim US-Pharmakonzern Merck

(Korrigiert wird im ersten Absatz, zweiter Satz wegen eines Tippfehlers die Formulierung zu Gardasil. Es handelt…

Hohe Forschungskosten sorgen für Gewinneinbruch beim US-Pharmakonzern Merck

RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co hat das vergangene Jahr unerwartet stark beendet.…

Merck & Co: Erfreulicher Minimalgewinn - Aktienanalyse

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Keytruda strength fuels earnings beat for Merck By Investing.com

Keytruda strength fuels earnings beat for Merck…

Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales

Merck still posted a quarterly loss due to previously announced charges associated with its cancer drug collaboration deal with Daiichi…

Merck posts better-than-expected quarterly results on soaring Keytruda sales By Reuters

Merck posts better-than-expected quarterly results on soaring Keytruda sales…

Merck’s fourth-quarter results top estimates, fueled by key cancer drugs and vaccines

Merck on Thursday reported fourth-quarter earnings and sales that beat analyst expectations, powered by strong growth in cancer and vaccine…

Antibiotics Market revenue to surpass USD 108 Billion by 2035, says Research Nester

Major antibiotics market players include F.Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA vor Zahlen zum vierten Quartal auf…

Merck (MRK) Q4 Earnings Beat, Sales Miss, Upbeat 24 View

Merck (MRK) beats Q4 estimates for earnings but misses the mark on sales. The company issues an encouraging 2024 guidance.…

Ausblick: Merck stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor

Merck wird am 01.02.2024 die Bilanz zum am 31.12.2023 abgelaufenen Quartal präsentieren.Die Schätzungen von 19 Analysten belaufen sich beim EPS…

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for…

Merck: Big Pharma Looks Stronger Than Ever Ahead Of 2023 Earnings

…

Führungswechsel: Merck-Eigentümer bekommt neuen Vorsitzenden

Johannes Baillou übernimmt die Führung des Familienrates von Merck. Der bisherige Vorsitzende, Frank Stangenberg-Haverkamp, geht nach vierzig Jahren in den…

DAX weiter über 16.900 – Adidas, Bayer, Merck, Porsche AG, RWE und Siemens Energy im Check

Auf Schlusskursbasis hat der DAX am Freitag auf einem neuen Rekordhoch geschlossen. Immer noch hoffen die Anleger darauf, dass die…

Merck: Set To Keep Soaring Post Q4 Release

…

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

Fast-approaching patent expirations will take a bite out of revenues and put the industrys top players in the hot seat…

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

The CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen.…

Merck’s Keytruda cuts bladder cancer risk by 31% in Phase 3 trial

…

AbbVie And Merck: Defensive Healthcare Plays Providing Income

…

Merck: Platz 2 im DAX - deshalb geht es bergauf

Heute ist der größte Gewinntag für die Merck-Aktie seit dem 21. Juli 2022 (+5,92 Prozent). Es geht um sieben Prozent…

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

Collaboration will support the initiation of a combination arm in the ongoing Phase 1/2a trial in patients with mCRPC…

dpa-AFX ProFeed